– GEN’s Editor-in-Chief John Sterling interviews Felix Theeuwes, D.Sc., Chairman, Co-founder, and Chief Scientific Officer at DURECT Corporation.

Previous articleFDA Licenses First Avian Flu Vaccine for Humans
Next articleBioFocus DPI and AstraZeneca Sign Second Discovery Transaction